9/29/2017 Ambulatory Services Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowAmbulatory care refers to the medical services provided on an outpatient basis without hospitalization or other medical facility. Outpatient services include physician and dentist offices, medical laboratories, and home healthcare. Ambulatory care service is one of the major contributor to the hospital revenue and to the performance of the health care system. Ambulatory care provides diagnosis, observation, consultation, treatment, intervention, and rehabilitation services to patient with advanced medical treatments. In addition, telephone consultations, rehabilitation visits, and emergency visits to the patients is expected to attract more patients towards the services, offering greater contribution to financial outcome.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/832 Cost saving surgeries drives the growth of the global ambulatory services market According to the Centers for Medicare and Medicaid Services in 2016, approximately 35 million ambulatory surgical visits and 20 million surgical procedures were performed in hospital outpatient departments (HOPDs), with 15 million surgeries performed in ambulatory surgery centers (ASCs). Also, Medicare payments to ASCs have increased by 24% from $2.9 billion in 2007 to $3.6 billion in 2012. The factors driving the growth of ambulatory services include, rising government funding offering team-based primary care, cost-saving surgeries compared to the hospitals, and government investment for ambulatory care facilities. Additionally, the growing prevalence of chronic diseases with increasing geriatric population, advancement in technology, and new reimbursement rules by the government offering economic advantage are the factors leading to the growth of the global market. Also, the demand for minimally invasive surgeries, faster patient recovery with shorter healing time, inexpensive surgical charges, and well equipped ambulatory service centers is expected to drive the market in the forecast period. However delayed diagnosis, ineffective communication, and incidence of adverse drug events are restrains for ambulatory services market. Hospital-based ambulatory surgical centers segment is expected to witness higher growth rate owing to value added services The global ambulatory services market is segmented on the basis of center, modality, service, application and geography. On the basis of centers, the global ambulatory services market is segmented into:
On the basis of modality, the global ambulatory services market is segmented into:
On the basis of services, the global ambulatory services market is segmented into:
On the basis of applications, the global ambulatory services market is segmented into:
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/ambulatory-services-market-832 Introduction of outpatient strategies is expected to accelerate the ambulatory services market in Asia Pacific Regional segmentation of the global ambulatory services market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. According to the National Center for Health Statistics estimates in 2017, the number of outpatient surgery visits in the U.S. is increased from 2006 to 2016, from 20.8 million to 34.7 million visits, thereby raising the demand for ambulatory services. North America is expected to dominate the ambulatory services market owing to cost-saving offers eliminating hospital stays, shift of aging population to outpatient care, and expansion of network with physicians and healthcare providers. For instance, the partnership of Tenet Healthcare and United Surgical Partners International (USPI) in 2015 resulted in undertaking 20 imaging centers, 265 short-day surgical facilities with 4000 physicians. The demand for ambulatory services in Europe is expected to increase owing to event organizations by British Association of Day Surgery and Healthcare Conferences UK, to create awareness among patients and to improved quality of surgery. Asia-Pacific is expected to grow drastically in the forecast period owing to the increasing healthcare issues with rising incidence of chronic diseases, and government initiation to introduce outpatient strategies. For instance, the launch of mobile apps by China and Japan are providing medical knowledge and easy booking for outpatient appointments. Comprehensive medical services offered by the keyplayers fuels the demand of ambulatory services market Key players operating the global ambulatory services market include Symbion, IntergraMed America Inc., AmSurg Corp., Terveystalo Healthcare and DaVita HealthCare. The strategies applied by the key players include mergers and collaborations to offer comprehensive medical services. For instance, the acquisition of Premier Emergency Medical Specialists (PEMS) by AmSurg in 2015 marked its entry into emergency medicine specialty. Other vendors include SurgCenter, LVL Medical Group, Fresenius Kabi, Apria Healthcare and Healthway Medical Corporation Limited. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
0 Comments
9/27/2017 Powered Surgical Instruments Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowPowered surgical instruments are precisely designed surgical instruments used to reduce time of surgical procedures and give consistent performance and functionality. These instruments are powered by external sources such as electricity or batteries. The advancements in the conventional powered surgical instruments has increased their use in numerous surgical areas such as in neurosurgery, orthopedic surgery, otology, dental surgery and some others. Every powered surgical instrument consist of a power source and many hand pieces which are required to perform specific functions. Development in the interchangeable accessories has made the surgical procedures safer and faster. Number of companies, physicians, and dentists are contributing to rapidly growing powered surgical instruments market.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/803 Rising medical tourism globally is an important factor propelling the growth of powered surgical instruments market According to Health Research Funding (HRF) in U.S., around 400,000 robotic surgeries were performed among all type of surgeries in 2012 and the cost of these surgeries is increasing by 25% every year. The other factors fuelling to the growth of powered surgical instruments market include rising geriatric population, the growing number of patient with chronic diseases such as cancer, cardiovascular diseases, orthopedic conditions, and neurological diseases. Additionally, factors owing to the growth of powered surgical instruments market include, medical tourism, increased healthcare expenditure, rising cases with surgical procedures, growing accessibility to healthcare facilities, and rapid advancement in technology However, the factors that might hinder the growth of powered surgical instruments market include lack of skilled persons to handle these instruments, stringent policies to reduce the healthcare cost, absence of sterilization processes, and lack of quality assurance. Whereas the untapped market in emerging countries is expected to provide numerous opportunities for the growth of powered surgical instruments market. Electric powered surgical instruments accounted for the maximum share in powered surgical instruments market due to their lower prices and applications in numerous surgical areas The global powered surgical instruments market is segmented by power source, application, product, and region On the basis of power source, the powered surgical instruments market is segmented into
On the basis of applications, the powered surgical instruments market is segmented into
On the basis of product type, the powered surgical instruments market is segmented into
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/powered-surgical-instruments-market-803 Increase in medical tourism fuelling to the growth of powered surgical instruments market in Asia Pacific Regional segmentation of powered surgical instruments market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. North America dominates in the power surgical instruments market due to the presence of well-established healthcare facilities and rise in geriatric population.. Asia Pacific is also expected to propel in the powered surgical instruments market owing to factors such as increase in accessibility to healthcare facilities, rising medical tourism, and increase in prevalence of chronic diseases with requirement of surgical procedures. Major industry players are involved in the expansion of product portfolio and geographical presence to hold the major share in the powered surgical instruments market Key industry players operating in the Powered surgical instruments market include Johnson & Johnson, B. Braun Melsungen AG, Stryker Co., Medtronic Incorporated, Smith & Nephew, Conmed Co., and Zimmer Holdings. The major industry players are trying to expand their product portfolio and opting for geographical expansion to lead in the powered surgical instruments market. For instance, Stryker Co. has expanded product portfolio that include small bone, large bone, and high speed powered surgical instruments and accessories. The new players in the powered surgical instruments market might adopt the strategies such as market penetration, market diversification, and product innovation and development. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/25/2017 Smart Home Medical Device Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2024Read NowPost-discharge care plays an extremely important role in ensuring speedy and effective recovery of the patient. This is especially a matter of concern for the elderly as well as pediatric population who mostly spend their time at home and are usually dependent on someone else to ensure continued care. However, due to busy lifestyle of the populace in developed and emerging economies, post-discharge care is often hampered. This concern of family members as elderly people living alone is expected to favor growth of the market for smart home medical devices, such as fall detection system, bathroom sensors, monitoring and detecting systems and assisting systems. According to a Welfare Ministry Survey, in 2016, there were around 6.24 million people aged 65 and above were living alone in Japan. The increasing lonely deaths in the region is also a vital factor that is expected to favor the smart home medical device market.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/111 Global smart home medical device market taxonomy The global smart home medical device market is classified on the basis of following segments: Product Type: Detection and monitoring systems
Digital pills Wearable
Growing internet penetration favors growth of smart home medical devices market: Smart home medical device is latest and futuristic approach towards making life easier and secure. This revolutionary step by the medical devices company has affected the healthcare industry and the adoption rate for such technology in a positive way. While most consumers and healthcare organizations were skeptical about the technology, the scenario is rapidly changing, with higher adoption rate of such devices, a trend that is expected to continue over the forecast period. Furthermore, the wide availability of the smart home medical devices is a crucial block to fill the loop hole for acceptance of such devices and services. Easily available personal monitoring system and other electronic devices are expected to favor rise in adoption of smart home medical devices. Smart home basically defined as the residence that uses controllers to integrate the functions of the device installed at home. The controllers are connected through a computer that is connected via internet and the data of the respondent is recorded on cloud or on-premises data bank, which can be further monitored by the physician or caretaker accordingly. Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/smart-home-medical-device-marke-111 Growth in adoption of health caregiving is expected to underpin the smart home medical device market According to American Association of Retired Persons (AARP), in 2016, around 80% growth has been observed in the medication management segment in the health caregiving market, which in turn is expected to support growth of the smart home medical device market in the near future. Medical technology utilized in home care settings, where the caregivers are active, ranges between complex and simple materials that are also used for administering first aid to sophisticated devices and advanced medical treatment. The products involved in home care settings can vary from tiny wireless devices to massive machines. Smart home medical devices such as blood pressure measuring equipment, sugar level measuring equipment and devices are widely used. Highly fragmented market due to dominance of ICT organizations in smart home medical device manufacturing The global smart home medical device market is highly fragmented market as encompasses pharmaceuticals, healthcare and information and communication technology industries. Growth in internet of things segment and its acceptance globally is expected to support the market for smart home medical device. Although, it is a difficult task to align the technology to the human vitals, incorporating the appropriate features into a medical device that are utilized by the patient or the care recipient at home is the most challenging factors for such devices. Major players involved in the smart home medical device market include ViVO Smart Medical Devices Ltd., Health Care Originals, Hocoma AG, VitalConnect, Proteus Digital Health, Cyrcadia Health, Qardio, Inc., and Neurometrix. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/22/2017 Cell Lysis Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowCells are defined as the basic unit of life that can replicate independently also referred to as the building blocks of life. Cells contain biomolecules such as proteins or nucleic acids present in the cytoplasm and enclosed within a membrane.
Cell lysis is a process in which a cell membrane is ruptured due to some external forces or conditions such as viral infection or osmosis, resulting in the release of cell contents, thus resulting in subsequent death of the cell. In industries and research laboratories, cell lysis is often used to break open the cell to study its internal components. The two methods through which cell lysis can be achieved include mechanical and chemical methods. Mechanical cell lysis method includes high shear mixing, sonication, freeze or thaw cycles, traditional homogenization, grinding, and high pressure homogenization whereas, chemical lysis method comprises of osmotic lysis, and the use of detergents, chelating agents, and chaotropic agents. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/741 The increase in protein purification studies/concept to boost the cell lysis market The major factors contributing to growth of the cell lysis market are increase in research and development activities in industries. The research activities being carried out in the biotechnology and pharmaceutical industries are related to protein, DNA, and RNA, to help explore prospects of novel biotherapeutic and pharmaceutical drugs. The extraction of proteins or nucleic acid is not possible without cell lysis, thus driving growth of the market. The other factors driving the cell lysis market growth include the increasing number of cancer cell studies, lung diseases, biotechnology firms, and growing focus on personalized medicine. However, one of the biggest challenges that the market is coping with is high costs associated to cell-based research. Cell lysis market can be segmented on the basis of product type, instruments, cell type, applications, end-user, and geography On the basis of product type, the cell lysis market is segmented into:
On the basis of instrument, the cell lysis market is segmented into:
On the basis of cell type, the cell lysis market is segmented into:
On the basis of applications, the cell lysis market is segmented into:
On the basis of end-user, the cell lysis market is segmented into:
On the basis of regions, cell lysis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the largest region in the global market for cell lysis, followed by Europe. Asia Pacific is expected to be the fastest growing cell lysis market due to its increasing geriatric population, stabilizing economy, and development in the biotechnology and pharmaceutical sector. Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/cell-lysis-market-741 The medical research and genomics study on various diseased cells is expected to boost the cell lysis market Becton Dickinson, one of the leading companies in the cell lysis market, provides medical technologies and innovative solutions globally, thereby improving the diagnosis of infectious diseases, cancer, medication management, and promotion of infection prevention. The other key players involved in the cell lysis market are Beckman Coulter, Bio- Rad Laboratories, Cell Signaling Technology, Thermo Fisher Scientific, Qiagen N.V., Qsonica, Merck KGaA, and F. Hoffman-La Roche AG. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/22/2017 Cell Lysis Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowCells are defined as the basic unit of life that can replicate independently also referred to as the building blocks of life. Cells contain biomolecules such as proteins or nucleic acids present in the cytoplasm and enclosed within a membrane.
Cell lysis is a process in which a cell membrane is ruptured due to some external forces or conditions such as viral infection or osmosis, resulting in the release of cell contents, thus resulting in subsequent death of the cell. In industries and research laboratories, cell lysis is often used to break open the cell to study its internal components. The two methods through which cell lysis can be achieved include mechanical and chemical methods. Mechanical cell lysis method includes high shear mixing, sonication, freeze or thaw cycles, traditional homogenization, grinding, and high pressure homogenization whereas, chemical lysis method comprises of osmotic lysis, and the use of detergents, chelating agents, and chaotropic agents. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/741 The increase in protein purification studies/concept to boost the cell lysis market The major factors contributing to growth of the cell lysis market are increase in research and development activities in industries. The research activities being carried out in the biotechnology and pharmaceutical industries are related to protein, DNA, and RNA, to help explore prospects of novel biotherapeutic and pharmaceutical drugs. The extraction of proteins or nucleic acid is not possible without cell lysis, thus driving growth of the market. The other factors driving the cell lysis market growth include the increasing number of cancer cell studies, lung diseases, biotechnology firms, and growing focus on personalized medicine. However, one of the biggest challenges that the market is coping with is high costs associated to cell-based research. Cell lysis market can be segmented on the basis of product type, instruments, cell type, applications, end-user, and geography On the basis of product type, the cell lysis market is segmented into:
On the basis of instrument, the cell lysis market is segmented into:
On the basis of cell type, the cell lysis market is segmented into:
On the basis of applications, the cell lysis market is segmented into:
On the basis of end-user, the cell lysis market is segmented into:
On the basis of regions, cell lysis market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the largest region in the global market for cell lysis, followed by Europe. Asia Pacific is expected to be the fastest growing cell lysis market due to its increasing geriatric population, stabilizing economy, and development in the biotechnology and pharmaceutical sector. Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/cell-lysis-market-741 The medical research and genomics study on various diseased cells is expected to boost the cell lysis market Becton Dickinson, one of the leading companies in the cell lysis market, provides medical technologies and innovative solutions globally, thereby improving the diagnosis of infectious diseases, cancer, medication management, and promotion of infection prevention. The other key players involved in the cell lysis market are Beckman Coulter, Bio- Rad Laboratories, Cell Signaling Technology, Thermo Fisher Scientific, Qiagen N.V., Qsonica, Merck KGaA, and F. Hoffman-La Roche AG. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/21/2017 Biosimilars Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowBiosimilars are biological medical products which are the identical copies of the original products. Biosimilars are also termed as subsequent entry biologic or follow-on biologic. Biosimilars are expected to possess active properties, similar to that of officially approved original product at present. Biosimilars can be manufactured only when the patent for the original innovator product expires. Biologics or biosimilars are sensitive to changes in manufacturing process due to the higher molecular complexity. In 2010, The Food and Drug Administration (FDA) has gained the authority to approve biosimilars as a part of Patient Protection and Affordable Care Act. The approval process is based on thorough demonstration of similarity and comparability with the existing approved product. Biosimilars are generally derived from living cells of plants, animals, yeast, bacteria and viruses, through genetic engineering processes including controlled gene expression and recombinant DNA technology.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/750 Patent expiry of blockbuster drugs and increasing government initiatives for biosimilars promotion drives the growth of biosimilars market The key factors driving the growth of biosimilars market are the increasing demand due to their cost-effectiveness, rising geriatric population, growing pressure to curtail healthcare expenditure, increasing government support and initiatives to develop and promote biosimilars, strategic collaborations to enhance productivity and clinical trial activities for biosimilars. According to the American Health and Drug Benefits in 2013, the average biosimilars sale was more than U.S. $1 billion annually. For instance the global sales was projected to be around U.S. $7.19 billion for Remicade (infliximab) and U.S. $5.98 billion for Avastin (bevacizumab), leading to the higher approval by the doctors and patients of biosimilars globally. Also, the early phase of biosimilars market, easy entry, high growth opportunity, agreement for improved reimbursements with insurance companies are further driving the biosimilars market. The expiry and termination of numerous blockbuster pharmaceuticals drugs like Humira, Enbrel and Remicade in the next 5 to 10 years is the primary driver providing significant opportunity for new players to enter the market. Diabetes medicine and oncology segments are expected to attain faster growth during the forecast period The global biosimilars market is segmented on the basis of product type, manufacturing type, application, end user and geography. On the basis of product type, the global biosimilars market is segmented into:
On the basis of by manufacturing type, the global biosimilars market is segmented into:
On the basis of application, the global biosimilars market is segmented into:
Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/biosimilars-market-750 Cost effective potential of biosimilars is the primary factor expected to boost the biosimilars market in Asia Pacific Regional segmentation of the biosimilars market by Coherent Market Insights comprises North America, Europe, Asia-Pacific, Latin America and Middle East and Africa. The first FDA approval biosimilar in 2015, Sandoz’s Zarxio has marked a promising hit of the biosimilars market across North America. According to the American Society of Health-System Pharmacists survey in 2013, about 99% of 214 surveyed pharmacy directors reported at least one oncologic drug shortage with the consequences of adopting the distribution of biosimilars to meet the rising demands. Also, the demand for biosimilars is expected to gather momentum in North America owing to the rising prevalence of cancers, autoimmune diseases, kidney failures and growth hormone deficiency and increasing approval rates by FDA. The treatment for various diseases including diabetes, rheumatoid arthritis and types of cancers are anticipated to become affordable in developing countries like China and India, thus providing opportunities for major players in the Asia Pacific biosimilar market to expand during the forecast period. Additionally, the Asia-Pacific market is expected to witness higher growth owing to economic biopharmaceuticals or the low- cost of biosimilars, high adoption rate and consistent guidelines issued by the regulatory authority. The increase in product extensions integrated with technological innovations is expected to intensify the competitive environment within manufacturers Key players operating in the biosimilars market include Sandoz International GmbH, Apotex, Biocon, Zydus Cadila Healthcare, Celltrion and Pfizer. The leading manufacturers are focusing on outsourcing the production of biosimilar products with strategic collaborations to replace the existing expensive drugs. For instance, in August 2016, the FDA approval by Sandoz for the biosimilar Erelzi, used for treating multiple inflammatory diseases such as rheumatoid arthritis, plaque psoriasis, ankylosing spondylitis and juvenile idiopathic arthritis. The other prominent vendors include Hexal, Accord Healthcare, Harvest Moon Pharmaceuticals, Eli Lilly and Teva Pharmaceuticals. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/20/2017 Pulse Oximeter Market by product type, and end-user - Global Industry Insights, Trends, Size, Share, Outlook, and Opportunity Analysis, 2017–2025Read NowMajor players operating in pulse oximeter market
There are few big brands that are expected to favor the growth of pulse oximeter market. The Apple watch used pulse oximeter technology for its heart rate monitor which has increased the market size of pulse oximeter. Key players operating in pulse oximeter market are CAS Medical Systems Inc., Covidien Plc, Masimo Corporation, Nihon-Kohden Corp., Nonin Medical Inc., Opto Circuits Ltd., Criticare Systems Inc., Mediaid Inc., Spacelabs Health care Inc., Philips Healthcare and Welch Allyn Inc. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/467 Pulse oximeter is a noninvasive device used for monitoring a person’s oxygen saturation (SO2). In its most common application mode, a sensor device is placed on thin part of the patient body, which is usually a fingertip or earlobe in adults and in case of infants it is placed across a foot. The pulse oximeter displays the percentage of blood that is loaded with oxygen. Pulse oximeter specifically measures the percentage of hemoglobin, the protein in blood that carries oxygen. Pulse oximeter is particularly convenient for continuous measurement of blood oxygen saturation noninvasively. Pulse oximeter can be used in any setting where patient’s oxygenation is not stable such as in intensive care, recovery, operating, emergency and hospital ward, pilots in unpressurized aircraft, patient at high altitude for assessment of any patient’s oxygenation and to determine whether there is need for supplemental oxygen.Furthermore, the simplicity of use and ability to provide continuous and immediate oxygen saturation values makes pulse oximeters of critical importance in emergency medicine or first aid. Pulse oximeter Furthermore, the simplicity of use and ability to provide continuous and immediate oxygen saturation values makes pulse oximeters of critical importance in emergency medicine or first aid. Pulse oximeter are useful for patients with cardiac problem, respiratory problem and chronic obstructive pulmonary disease. Moreover, pulse oximeter are used for diagnosis of sleeping disorders such as hypopnea and apnea. The pulse oximeter with portable battery are useful for pilots operating in a non-pressurized aircraft where supplemental oxygen is required. Pulse oximeter are also used extensively used by mountain climbers and athletes whose oxygen level may decrease at high altitude or with extensive workout. Pulse Oximeter Market Taxonomy By Product Type
By End Users
Driving forces for the growth of pulse oximeter market in the near future: Enhancement in healthcare workers to efficiently adopt the improved and reliable detection algorithms, increasing awareness and high prevalence of diseases that require continuous monitoring are the driving forces of pulse oximeter market. Furthermore, pulse oximeter market is also driven by technology advancements and also in expansion of clinical applications such as in critical care, childbirth, neonatal, surgery, anesthesia and pediatric care. Increasing demand for pulse oximeter is mainly linked to its portability, connectivity, and small size. Moreover, increase in aging population according to International Journal of Health Policy and Management showed periodic increase during 2004-2012 of aging associated increase in hospitalization, which was pegged at 1.03 million globally. This in turn is expected to favor growth of the pulse oximeter market. Standardization of patient monitoring in clinical practice creates a highly conducive environment for growth of the global pulse oximeter industry. Growing use of alternate care facilities and development in R&D also drives the market of pulse oximeter. However, according to National Sleep Foundation, in 2012, around 40 million people in the U.S. suffered from chronic sleep disorder which suggest the increased use of pulse oximeter. Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/pulse-oximeter-market-467 Regional growth engines of the pulse oximeter market According to Centers for Disease Control and Prevention (CDC) and American Academy of Pediatrics (AAP) in September 2014 mandatory critical congenital heart defects (CCHD) screening for new born is a key reason for dominance of U.S for market of pulse oximeter market. Asia Pacific is assumed to observe fastest growth in near future due to increase in investment of industry player in this region is a key reason for growth of market. According to The European Sleep Apnea Database (ESADA), of March 2014, the number of enrollment of patients has reached to 15,956 along with 5313 follow up visits which shows that pulse oximeter market is rising in Europe About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/19/2017 Melanoma Treatment Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowMelanoma is a type of skin cancer that develops from the pigment cells known as melanocytes. It is caused due to high exposure to ultraviolet rays, which leads to sunburn, especially at high altitudes. Melanoma is categorized into three: cutaneous, mucosal, and ocular. Cutaneous affects the skin, mucosal affects the mucous membrane in the mouth and nasal passage, and ocular affects the eye. However, early detection of melanoma helps in the treatment and increase survival rates. According to the American Academy of Dermatology 2015 report, the prevalence of melanoma is increasing and spreads to other body parts as well. As it spreads to other body parts, its treatment becomes much more complex. The rare genetic conditions such as xeroderma pigmentosum also increase the risk of melanoma and it is diagnosed with the biopsy of any skin lesion.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/719 Melanoma Treatment Market Taxonomy: The global melanoma treatment market is segmented as follows; By Melanoma Type;
By Therapy;
Development of new drugs fuels the melanoma treatment market Several drugs in the market have already received FDA approval for melanoma treatment and some are under development. Drugs such as seviprotimut-L by Polynoma’s, talimogene laherparepvec (T-VEC) by Amgen Inc., and zelboraf, by Roche and Genetech together for the treatment of cutaneous melanoma are under development. Selumetinib is under development by AstraZeneca for the treatment of ocular melanoma. In 2011, Yervoy, a monoclonal antibody drug was developed by Bristol-Myers Squibb for the treatment of melanoma and it is the first drug to receive FDA approval. Immunotherapy drugs include opdivo and keytruda, which got FDA approval and created new opportunities in melanoma treatment market. When chemotherapy fails to deliver results, targeted therapy is used, which include BRAF inhibitors. Targeted therapy has limited side effects in comparison with chemotherapy. According to Cancer Research Institute, in 2016, there were around 76,000 people diagnosed with melanoma in the U.S. The development of novel drugs and combination therapy with limited side effects and better survival rates is expected to fuel the melanoma treatment market growth. The increased focus on personalized medicine with a huge investment in anti-melanoma drugs is expected to create new opportunities in near future. However, high price of combination therapies and clinical trial with side effects act as restraints for the melanoma treatment market. Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/melanoma-treatment-market-719 Developed regions support the growth of melanoma treatment market Melanoma treatment market, based on geography, is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the melanoma treatment market due to the high prevalence of melanoma in the region along with well-developed healthcare facilities and increased research and development on melanoma drugs. Moreover, reimbursement policy and increase in per capita income are expected to fuel the melanoma treatment market. Europe is the second largest market and is expected to grow significantly in near future due to increase in melanoma cases and development of novel therapies. Asia Pacific is expected to exhibit moderate growth due to fewer cases of skin cancer, lack of awareness, and high cost of melanoma drugs. Key Players in the Global Melanoma Treatment Market Some of the key players identified across the value chain of global melanoma treatment market are Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Genetech Inc., Novartis AG, Polynoma LLC, AstraZeneca, Amgen Inc., Sanofi, Merck & Co. Inc., and Takeda Pharmaceutical Company. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/19/2017 Ophthalmic Devices Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowOphthalmology refers to a branch of medical sciences that deals with the structural and functional defects of the eye. Ophthalmic devices are medical devices used in the treatment and identification of certain ocular deformities and deficiencies of the eyes. The global ophthalmic devices market is driven by eye disorders such as glaucoma, diabetic retinopathy, macular degeneration, and cataract and vision care devices. Ophthalmic devices are also used in various surgical processes such as ultrasound phacoemulsification for faster recovery rates and improved safety. A wide range of ophthalmic devices are available in the market from high complexity devices such as phoropters , ophthalmoscopes, retinoscopes and scanning laser polarimetry devices to low end products such as contact lenses, spectacles and lens cleaning and disinfecting solutions, Thus, the demand for ophthalmic devices is anticipated to be increasing significantly over the forecast period.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/686 Increasing prevalence of eye disorder is projected to fuel growth of the global ophthalmic devices market According to the International Journal of Advanced Medical and Health Research 2015, cataract has been reported to be the major cause of blindness, affecting 17-18 million people worldwide, accounting for 39% of such cases. Following cataract, glaucoma is seen to be the second major reason causing blindness among people. According to the Glaucoma Research Organization, over 120,000 people are blind due to glaucoma accounting up to 9-12% of total blind cases. These massive numbers are basically the output of eye disorders prevalence in the geriatric population and changing food habits leading to nutritional deficits in the younger population. The ophthalmic devices can be used in order to treat cataract, glaucoma and several other eye disorders that could propel the global ophthalmic devices market. The vision care devices segment dominating the global ophthalmic devices market in terms of over the counters sales The global ophthalmic devices market is segmented on the basis of product type, disorder, and geographical region. On the basis of product type, the global ophthalmic devices market is segmented as
Vision care devices witnesses maximum sale over the counter and therefore accounts for the largest share. Furthermore there is a rapid rise in number of people affected with eye disorders and increasing awareness among the populace about eye health and safety augments growth of the segment. According to The Vision Council, over 87% of people in the U.S. are reported to be using digital devices for over 2 hours per day, thereby developing eye strain, dry eyes, blurred vision, etc. These small eye related troubles can be sorted with the use of vision care devices in turn potentiating the global ophthalmic devices market. Moreover, rapid growth in the eye diseases such as cataract and glaucoma are resulting in potential growth of the surgical devices segment that would be required in the treatment of these disorders. On the basis of disorders, the global ophthalmic devices market is segmented as
Emerging economies of Asia Pacific to boost global ophthalmic devices market growth in the forecast period Based on regional segmentation, the global ophthalmic devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. The North America is accounted to capture highest share in the global ophthalmic devices market owing to innovation and focus on diagnostic devices and surgery applications as well as higher market penetration levels. The emerging economies such as China, India, Japan and Brazil are estimated to gain an early momentum in the market as a result of massive investments by manufacturers. Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/ophthalmic-devices-market-686 Governments in developing countries focusing towards eye safety and vision care thereby mushrooming the global ophthalmic devices market The annual rise in the prevalence of eye disorders such as cataract, glaucoma and macular degeneration are the major drivers of the global ophthalmic devices market. Several other factors that are responsible to bolster the growth of ophthalmic devices market includes advent of technologically advanced minimally invasive surgery, rise in geriatric population and demand for surgical and diagnostic instruments. The growing occurrence of eye disorders in children will also add up to fuel the market growth. The governments in developing countries supporting to establish sophisticated healthcare infrastructure and eye care centers will in turn favor growth of the global ophthalmic devices market. However, the inadequate awareness among the developing nations regarding vision care and treatments related to eye disorders can inhibit the market growth. The global ophthalmic market is very vast, rapidly growing as well as highly competitive. Some of the major players operating global ophthalmic market are Johnson and Johnson, Novartis AG, Bausch & Lomb Inc., Essilor International, Abbott Laboratories Inc., VisionCare Inc., Hoya Corporation, Canon Inc., Carl Zeiss AG, Topcon Corporation, Nidek Co Ltd., CooperVision AG and Alcon Inc. The players are sustaining their prime position in the global ophthalmic devices market due to consistency in launching of new ophthalmic devices and eye care products. Alongside, several other new entrants may also create growth opportunities and enhance the growth of the global ophthalmic devices market. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. 9/18/2017 Interventional Cardiology Devices Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2025Read NowInterventional cardiology is the branch of cardiology that specifically deals with catheter based treatment of heart diseases, such as congenital heart defect (CHD), coronary artery disease, and aneurysm. This involves insertion of the catheter into femoral artery or any large peripheral artery or vein and through catheter whole procedure is performed by using fluoroscopy. Interventional cardiology has reduced the complications for patients as it provides, fast recovery, short hospital stay, and controlled bleeding. There is constant development in interventional cardiology devices, such as from bare metal stent to bio-absorbable stent. According to Centers for Disease Control and Prevention, which provides information about various diseases, there were around 40,000 children born with CHD in the U.S. in 2016. Interventional cardiology devices include catheters, guide wire, stents, filters, and balloons.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/691 Interventional cardiology devices market taxonomy: By Product Type
Request for Complete TOC before buying this exclusive Report by CMI: https://www.coherentmarketinsights.com/ongoing-insight/toc/691 Increased prevalence of cardiovascular diseases is expected to fuel the growth of interventional cardiology devices market There is a continuous increase in geriatric population and obesity which is leading to the increase in cardiovascular disease. For instance, as per United Nations report, there were around 901 million people of age 60 and above in 2015 and it is expected to reach 1.4 billion by 2050. Advancement in healthcare research, increasing patient awareness, and increase in the demand for minimal invasive surgery raise the demand for interventional cardiology devices. Interventional cardiology devices help interventional cardiologist to perform the procedure in short span of time, which reduces the risk and complication. The increase in obesity, geriatric population and lifestyle changes leads to the increase in coronary artery disease, for instance as per American Heart Association 2017 report, in the U.S. there was around 360,000 death caused due to coronary artery disease. With the prevalence of lifestyle diseases such as diabetes and hypertension has increased the cases of cardiovascular disorders. Continuous technological advancement in interventional cardiology devices and development of new systems with improved features such as new generation of drug eluting balloons and bio-absorbable stents are expected to support the growth in interventional cardiology devices market. Initiative taken by the Government to increase awareness about cardiovascular diseases and conduction of regular medical checkup camps has boosted the growth of market. Major challenges faced by interventional cardiology medical devices market is high manufacturing cost of these devices. Developed regions support the growth of interventional cardiology devices market Interventional cardiology devices market is segmented into various geographical regions such as North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America leads the interventional cardiology devices market because of the large geriatric population and sedentary lifestyle leading to cardiovascular disorders. According to Population Reference Bureau 2016, there were around 40 million people of age 60 and above, and it is expected to reach 89 million by 2050 in the U.S. Europe is closely following the North America in interventional cardiology devices market followed by Asia Pacific. However, Asia Pacific is expected to expand significantly in near future because of emerging economies such as India and China due to the increase in cardiovascular diseases, increased healthcare expenditure, per capita income of individual and increase in geriatric population, which is expected to support the growth of interventional cardiology devices market. Browse Research Report at: https://www.coherentmarketinsights.com/ongoing-insight/interventional-cardiology-devices-market-691 Key players to support the interventional cardiology devices market There are various players present across the globe contributing to the interventional cardiology devices market. Some key players are Abbott, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook Medical and B. Braun Melsungen AG. In 2017, Abbott acquired St Jude Medicals to increase the product pipeline, as St Jude Medicals are into atrial fibrillation, structural heart, heart failure and chronic pain and Abbott are leading in coronary inventions, which increase the market share and fuels the growth of interventional cardiology devices market. About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. |
Details
Global Industry Research Experienced Professional Freelancer with a demonstrated history of working in the information technology and services industry. Skilled in Front Office, Customer Service, Marketing, Microsoft Office, and Social Media. Strong media and communication professional with a Bachelor of Commerce - BCom focused in Computer and Information Sciences and Support Services from Pune University. Archives
July 2020
Categories |